BB Biotech AG logo

BB Biotech AG

XSWX:BION (Switzerland)  
CHF 41.90 (+0.6%) May 31
P/E:
At Loss
P/B:
0.87
Market Cap:
CHF 2.30B ($ 2.53B)
Enterprise V:
CHF 2.65B ($ 2.92B)
Volume:
59.20K
Avg Vol (2M):
55.84K
Also Trade In:
Volume:
59.20K
Market Cap CHF:
2.30B
Market Cap $:
2.53B
PE Ratio:
At Loss
Avg Vol (2M):
55.84K
Enterprise Value CHF:
2.65B
Enterprise Value $:
2.92B
PB Ratio:
0.87

Business Description

Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset 0.88
Debt-to-Equity 0.14
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate 6.2
3-Year Book Growth Rate -4
Name Current Vs Industry Vs History
5-Day RSI 25.96
9-Day RSI 26.33
14-Day RSI 27.12
6-1 Month Momentum % -23.48
12-1 Month Momentum % -20.4

Liquidity Ratio

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2023-07-21)

XSWX:BION's 30-Y Financials
Balance Sheet Breakdown
Cashflow Statement Breakdown

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

BB Biotech AG Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) -351.227
EPS (TTM) (CHF) -6.5
Beta -0.09
Volatility % 20.6
14-Day RSI 27.12
14-Day ATR (CHF) 0.941147
20-Day SMA (CHF) 44.3
12-1 Month Momentum % -20.4
52-Week Range (CHF) 41.45 - 63.8
Shares Outstanding (Mil) 54.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BB Biotech AG Filings

Document Form Filing Date
No Filing Data

BB Biotech AG Stock Events

Event Date Price(CHF)
No Event Data

BB Biotech AG Frequently Asked Questions

What is BB Biotech AG(XSWX:BION)'s stock price today?
The current price of XSWX:BION is CHF41.90. The 52 week high of XSWX:BION is CHF63.80 and 52 week low is CHF41.45.
When is next earnings date of BB Biotech AG(XSWX:BION)?
The next earnings date of BB Biotech AG(XSWX:BION) is 2023-07-21.
Does BB Biotech AG(XSWX:BION) pay dividends? If so, how much?
The  Dividend Yield %  of BB Biotech AG(XSWX:BION) is 6.8% (As of Today), Highest Dividend Payout Ratio of BB Biotech AG(XSWX:BION) was 0.27. The lowest was 0. And the median was 0.26. The  Forward Dividend Yield % of BB Biotech AG(XSWX:BION) is 6.8%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release